Imaging & Diagnostics

NHS Staff Shortages Cause Dangerous Cancer Treatment Delays
Imaging & Diagnostics NHS Staff Shortages Cause Dangerous Cancer Treatment Delays

The current trajectory of the National Health Service suggests a precarious reality for patients who require immediate oncology interventions and specialized diagnostic imaging to survive their conditions. A comprehensive analysis by the Royal College of Radiologists reveals a systemic failure to

New Blood Tests Transform Alzheimer's Disease Diagnosis
Imaging & Diagnostics New Blood Tests Transform Alzheimer's Disease Diagnosis

The medical community is currently witnessing a tectonic shift in the way neurological disorders are identified, as the era of guesswork and invasive spinal taps gives way to the precision of modern blood-based diagnostics. For decades, the path to a definitive Alzheimer’s diagnosis was a grueling

What Are the Keys to Radiopharmaceutical IND Success?
Imaging & Diagnostics What Are the Keys to Radiopharmaceutical IND Success?

The convergence of molecular biology and nuclear physics has fundamentally transformed the landscape of modern oncology, creating a paradigm where diagnostic precision meets therapeutic potency. These specialized chemical formulations, labeled with radioactive isotopes, have emerged as

How Will Ghana’s First Helium-Free MRI Change Patient Care?
Imaging & Diagnostics How Will Ghana’s First Helium-Free MRI Change Patient Care?

The landscape of medical diagnostics across West Africa is undergoing a profound transformation as the 37 Military Hospital in Accra introduces the first helium-free MRI system to the region. This technological leap, achieved through a strategic partnership between HealthTech Ghana Limited and the

FDA Approves Ambelvist as Lowest-Dose MRI Contrast Agent
Imaging & Diagnostics FDA Approves Ambelvist as Lowest-Dose MRI Contrast Agent

The medical community has spent decades searching for a way to maximize the diagnostic clarity of magnetic resonance imaging while simultaneously minimizing the volume of chemical substances introduced into the human body for visualization. For many years, physicians have balanced the necessity of

Can an Ebola Test Save This Struggling Biotech Firm?
Imaging & Diagnostics Can an Ebola Test Save This Struggling Biotech Firm?

The diagnostic medical landscape is currently witness to a high-stakes gamble where a single rapid detection kit might determine the survival of an enterprise facing significant fiscal headwinds. While the broader biotech sector has seen a cooling of venture capital interest compared to previous

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later